Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-12-02
DOI
10.3389/fonc.2020.580112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis
- (2020) Zheng Wang et al. Frontiers in Oncology
- Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study
- (2019) Kang Wang et al. EJSO
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery
- (2019) Caijin Lin et al. Journal of the National Comprehensive Cancer Network
- Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01
- (2018) Atilla Soran et al. ANNALS OF SURGICAL ONCOLOGY
- Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: ALTERNATIVE
- (2018) Stephen R.D. Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study
- (2018) Luca Gianni et al. LANCET ONCOLOGY
- Bone metastasis pattern in initial metastatic breast cancer: a population-based study
- (2018) Zhenchong Xiong et al. Cancer Management and Research
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- First-Line Trastuzumab Plus an Aromatase Inhibitor, With or Without Pertuzumab, in Human Epidermal Growth Factor Receptor 2–Positive and Hormone Receptor–Positive Metastatic or Locally Advanced Breast Cancer (PERTAIN): A Randomized, Open-Label Phase II Trial
- (2018) Mothaffar Rimawi et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis
- (2018) Elvire Pons-Tostivint et al. ANNALS OF SURGICAL ONCOLOGY
- Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
- (2018) Weikai Xiao et al. Cancer Management and Research
- Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer – Results from the prospective German Tumour Registry Breast Cancer cohort study
- (2017) Jan Schröder et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
- (2017) Véronique Diéras et al. LANCET ONCOLOGY
- Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
- (2017) Yue Gong et al. Scientific Reports
- Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study
- (2016) Anne Gulbech Ording et al. CLINICAL & EXPERIMENTAL METASTASIS
- Endocrine therapy and strategies to overcome therapeutic resistance in breast cancer
- (2016) Michael Robert Mancuso et al. CURRENT PROBLEMS IN CANCER
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pattern of metastasis and outcome in patients with breast cancer
- (2015) L. Gerratana et al. CLINICAL & EXPERIMENTAL METASTASIS
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
- (2015) Rajendra Badwe et al. LANCET ONCOLOGY
- Precision medicine for metastatic breast cancer—limitations and solutions
- (2015) Monica Arnedos et al. Nature Reviews Clinical Oncology
- Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
- (2014) M. Piccart et al. ANNALS OF ONCOLOGY
- Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival
- (2013) Julie E. Lang et al. ANNALS OF SURGICAL ONCOLOGY
- Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
- (2013) Dorien J. A. Lobbezoo et al. BREAST CANCER RESEARCH AND TREATMENT
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
- (2013) Sandra M Swain et al. LANCET ONCOLOGY
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Does primary tumor resection improve outcomes for patients with incurable advanced breast cancer?
- (2011) Susumu Shibasaki et al. BREAST
- Impact of breast surgery on survival in women presenting with metastatic breast cancer
- (2011) N. Bhoo Pathy et al. BRITISH JOURNAL OF SURGERY
- Surgery in metastatic breast cancer: Patients with a favorable profile seem to have the most benefit from surgery
- (2011) Z.M. Rashaan et al. EJSO
- Stage IV breast cancer in the era of targeted therapy
- (2010) Heather B. Neuman et al. CANCER
- Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis
- (2009) J. Ruiterkamp et al. EJSO
- Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients
- (2008) D Kay Blanchard et al. ANNALS OF SURGERY
- Matched Pair Analyses of Stage IV Breast Cancer with or Without Resection of Primary Breast Site
- (2008) B. Cady et al. ANNALS OF SURGICAL ONCOLOGY
- Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
- (2008) Grazia Arpino et al. ENDOCRINE REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now